SXI Life Sciences
7 459,18
|
31,80
|
0,43 %
|
Analysen zu SXI Life Sciences-Werten
05.09.25 | Novartis Neutral | UBS AG | |
04.09.25 | Roche Buy | UBS AG | |
02.09.25 | Novartis Hold | Jefferies & Company Inc. | |
01.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
29.08.25 | Novartis Neutral | UBS AG | |
27.08.25 | Novartis Buy | Deutsche Bank AG | |
22.08.25 | Novartis Neutral | UBS AG | |
21.08.25 | Novartis Buy | Deutsche Bank AG | |
12.08.25 | Novartis Neutral | JP Morgan Chase & Co. | |
04.08.25 | Novartis Outperform | Bernstein Research | |
01.08.25 | Roche Outperform | Bernstein Research | |
01.08.25 | Novartis Outperform | Bernstein Research | |
29.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
28.07.25 | Novartis Outperform | Bernstein Research | |
28.07.25 | Roche Buy | UBS AG | |
28.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
25.07.25 | Roche Kaufen | DZ BANK | |
24.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
24.07.25 | Roche Buy | UBS AG | |
24.07.25 | Roche Hold | Jefferies & Company Inc. | |
24.07.25 | Roche Outperform | Bernstein Research | |
23.07.25 | Roche Sell | Deutsche Bank AG | |
22.07.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.25 | Roche Sell | Deutsche Bank AG | |
22.07.25 | Novartis Neutral | UBS AG | |
21.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
18.07.25 | Novartis Kaufen | DZ BANK | |
18.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.07.25 | Novartis Buy | Deutsche Bank AG | |
18.07.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.07.25 | Novartis Neutral | JP Morgan Chase & Co. | |
17.07.25 | Novartis Outperform | Bernstein Research | |
17.07.25 | Novartis Hold | Jefferies & Company Inc. | |
17.07.25 | Novartis Neutral | UBS AG | |
14.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
10.07.25 | Roche Buy | UBS AG | |
09.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
08.07.25 | Roche Sell | Deutsche Bank AG | |
04.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
04.07.25 | Novartis Buy | Deutsche Bank AG |